S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover

BioMarin Pharmaceutical (BMRN) Short Interest Ratio & Short Volume

$91.24
+1.27 (+1.41%)
(As of 02/23/2024 ET)

BioMarin Pharmaceutical Short Interest Data

Current Short Volume
3,170,000 shares
Previous Short Volume
3,420,000 shares
Change Vs. Previous Month
-7.31%
Dollar Volume Sold Short
$279.21 million
Short Interest Ratio / Days to Cover
1.9
Last Record Date
January 31, 2024
Outstanding Shares
188,370,000 shares
Percentage of Shares Shorted
1.68%
Today's Trading Volume
3,652,648 shares
Average Trading Volume
1,338,855 shares
Today's Volume Vs. Average
273%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling BioMarin Pharmaceutical ?

Sign up to receive the latest short interest report for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BMRN Short Interest Over Time

BMRN Days to Cover Over Time

BMRN Percentage of Float Shorted Over Time


BioMarin Pharmaceutical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20243,170,000 shares $279.21 million -7.3%N/A1.9 $88.08
1/15/20243,420,000 shares $319.19 million -7.6%N/A2 $93.33
12/31/20233,700,000 shares $356.75 million -15.5%N/A2.2 $96.42
12/15/20234,380,000 shares $425.56 million +29.6%N/A2.4 $97.16
11/30/20233,380,000 shares $307.85 million +9.7%N/A2 $91.08
11/15/20233,080,000 shares $268.14 million -6.4%N/A2 $87.06
10/31/20233,290,000 shares $267.97 million -53.2%N/A2.5 $81.45
10/15/20237,030,000 shares $606.97 million +7.5%N/A6.1 $86.34
9/30/20236,540,000 shares $578.66 million -0.5%N/A5.6 $88.48
9/15/20236,570,000 shares $579.21 million +5.1%N/A5.1 $88.16
8/31/20236,250,000 shares $571.13 million +3.1%N/A5 $91.38
8/15/20236,060,000 shares $549.46 million -2.4%N/A4.8 $90.67
7/31/20236,210,000 shares $546.05 million -6.3%N/A5 $87.93
7/15/20236,630,000 shares $569.32 million +51.4%N/A5.3 $85.87
6/30/20234,380,000 shares $379.66 million -27.0%N/A3.6 $86.68
6/15/20236,000,000 shares $575.04 million -10.9%N/A5.7 $95.84
5/31/20236,730,000 shares $585.11 million -3.9%N/A5.9 $86.94
5/15/20237,000,000 shares $666.26 million +4.2%N/A5.5 $95.18
4/30/20236,720,000 shares $645.39 million +4.5%N/A5.1 $96.04
4/15/20236,430,000 shares $636.63 million +8.3%3.5%4.7 $99.01
3/31/20235,940,000 shares $577.61 million -2.8%3.3%4.1 $97.24
3/15/20236,110,000 shares $536.09 million -16.1%3.4%4.1 $87.74
2/28/20237,280,000 shares $725.02 million +7.9%4.0%4.9 $99.59
2/15/20236,750,000 shares $730.22 million +3.2%3.7%4.6 $108.18
1/31/20236,540,000 shares $754.39 million -2.4%3.6%4.3 $115.35
1/15/20236,700,000 shares $755.22 million -35.3%3.7%4.3 $112.72
12/30/202210,360,000 shares $1.07 billion -1.7%5.7%6.7 $103.49
12/15/202210,540,000 shares $1.14 billion +3.2%5.8%7.2 $108.61
11/30/202210,210,000 shares $1.03 billion +4.0%5.6%7.4 $100.98
11/15/20229,820,000 shares $846.29 million -12.9%N/A7.7 $86.18
10/31/202211,270,000 shares $976.32 million -3.5%6.2%9.7 $86.63
10/15/202211,680,000 shares $1.02 billion +1.4%6.4%10.9 $87.25
9/30/202211,520,000 shares $976.55 million +0.3%6.3%11.6 $84.77
9/15/202211,490,000 shares $1.01 billion +0.6%6.3%11.5 $88.09
8/31/202211,420,000 shares $1.02 billion +0.7%6.3%10.5 $89.20
8/15/202211,340,000 shares $1.10 billion -0.2%6.2%10.2 $96.94
7/31/202211,360,000 shares $977.53 million +0.8%6.3%9.5 $86.05
7/15/202211,270,000 shares $981.39 million -0.7%6.2%9.6 $87.08
6/30/202211,350,000 shares $940.57 million -3.2%6.2%9.4 $82.87
6/15/202211,720,000 shares $869.04 million +2.2%6.5%9.4 $74.15













BMRN Short Interest - Frequently Asked Questions

What is BioMarin Pharmaceutical's current short interest?

Short interest is the volume of BioMarin Pharmaceutical shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 3,170,000 shares of BMRN short. Learn More on BioMarin Pharmaceutical's current short interest.

What is a good short interest ratio for BioMarin Pharmaceutical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMRN shares currently have a short interest ratio of 2.0. Learn More on BioMarin Pharmaceutical's short interest ratio.

Which institutional investors are shorting BioMarin Pharmaceutical?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioMarin Pharmaceutical: GTS Securities LLC, Barclays PLC, Westchester Capital Management LLC, Wolverine Trading LLC, Citadel Advisors LLC, Cubist Systematic Strategies LLC, DeepCurrents Investment Group LLC, Verition Fund Management LLC, PEAK6 Investments LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, SpiderRock Advisors LLC, Cutler Group LLC CA, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is BioMarin Pharmaceutical's short interest increasing or decreasing?

BioMarin Pharmaceutical saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 3,170,000 shares, a drop of 7.3% from the previous total of 3,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does BioMarin Pharmaceutical's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to BioMarin Pharmaceutical: Alnylam Pharmaceuticals, Inc. (3.18%), United Therapeutics Co. (2.21%), Reata Pharmaceuticals, Inc. (9.44%), Ionis Pharmaceuticals, Inc. (6.03%), Alkermes plc (6.98%), Madrigal Pharmaceuticals, Inc. (19.45%), Viatris Inc. (2.86%), Teva Pharmaceutical Industries Limited (1.63%), Genmab A/S (0.31%), Sarepta Therapeutics, Inc. (5.53%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short BioMarin Pharmaceutical stock?

Short selling BMRN is an investing strategy that aims to generate trading profit from BioMarin Pharmaceutical as its price is falling. BMRN shares are trading up $1.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioMarin Pharmaceutical?

A short squeeze for BioMarin Pharmaceutical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BMRN, which in turn drives the price of the stock up even further.

How often is BioMarin Pharmaceutical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMRN, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:BMRN) was last updated on 2/25/2024 by MarketBeat.com Staff